Results 31 to 40 of about 10,606 (259)
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory ...
Yuichi Saito+4 more
doaj +1 more source
Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio+8 more
core +1 more source
Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device
Aims We sought to investigate the outcomes of heart transplant patients supported with Impella 5.5 temporary mechanical circulatory support. Methods and results Patient demographics, perioperative data, hospital timeline, and haemodynamic parameters were
Osama Haddad+10 more
doaj +1 more source
Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
Background Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. Case presentation We report three cases of successful intensive treatment by Impella of FM without any complications.
Takayuki Hori+3 more
doaj +1 more source
Impella-Induced Incessant Ventricular Tachycardia [PDF]
Background: The Impella 2.5 and Impella Cardiac Power (CP) devices (ABIOMED) are used to provide mechanical circulatory support for high-risk percutaneous coronary interventions or cardiogenic shock as a bridge to recovery or destination therapy.
Reema Hasan+7 more
openaire +3 more sources
316: Diuretic is safe and superior to volume expansion in normotensive patients with acute pulmonary embolism and right ventricular dilatation [PDF]
BackgroundThe rational and the benefit of load expansion is controversial in acute pulmonary embolism (PE). Diuretic may reduce RV preload and improve hemodynamic status.
Dubois Randé, Jean-Luc+6 more
core +1 more source
Background: Heart failure–related cardiogenic shock (HF-CS) is increasingly common. Moderate/severe functional mitral regurgitation (FMR) is commonly seen in patients presenting with decompensated heart failure and is associated with worse outcomes ...
Rachna Kataria, MD+8 more
doaj
Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used as mechanical circulatory support in cardiogenic shock (CS). It restores peripheral perfusion, at the expense of increased left ventricle (LV) afterload.
Francesca Fiorelli+1 more
doaj +1 more source
BackgroundIn selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking.
Veemal V Hemradj+17 more
doaj +1 more source
Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI
Objectives. To compare two different forms of mechanical circulatory support (MCS) in patients with complex high-risk indicated PCI (CHIP): the Impella CP system and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Background.
Deborah M.F. van den Buijs+10 more
doaj +1 more source